NDC 71287-219 – Tecartus

Brexucabtagene Autoleucel 2000000 1/68mL · Suspension · Intravenous

Cellular Therapy

Product NDC71287-219

Product details

Brand name
Tecartus
Generic name
Brexucabtagene autoleucel
Labeler
Kite Pharma, Inc.
Dosage form
Suspension
Route
Intravenous
Marketing category
BLA · BLA125703
Marketed since
July 24, 2020
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Tecartus →

Package NDC codes (1)

Package NDCDescriptionSince
71287-219-021 BAG in 1 PACKAGE (71287-219-02) / 68 mL in 1 BAG (71287-219-01)Jul 24, 2020

Other Tecartus products